Apos Recognized by NICE & NHS England's MedTech Funding Mandate Policy as a Cost ...

Retrieved on: 2024-07-08 00:00:28

Tags for this article:

Skeletal disorders

Health economics

Aging-associated diseases

Rheumatology

Arthritis

Osteoarthritis

National Health Service

Pain management

Knee replacement

National Institute for Health and Care Excellence

Mnemosyne

Click the tags to see associated articles and topics

Apos Recognized by NICE & NHS England's MedTech Funding Mandate Policy as a Cost .... View article details on hiswai:

Summary

The article describes the success of AposHealth's non-invasive knee osteoarthritis treatment device, Apos®, in being recognized by the National Health Service (NHS) England and the National Institute for Health and Care Excellence (NICE) as a cost-saving and effective MedTech innovation. Key concepts and tags like skeletal disorders, health economics, and arthritis focus on the broader implications of this technology for aging-associated diseases and pain management.

Article found on: www.einnews.com

View Original Article